文献速递认知障碍与痴呆帕金森病与运动障碍

弥漫性路易体病是可贡献于logopenic型进行性失语表型的病理因素

Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype.
PubMed 文献 · Ann Neurol · 2020-12-17

本诊所病理对照研究纳入45例患者,其中20例前瞻性招募的logopenic型进行性失语(LPA)患者中有6例病理诊断为弥漫性路易体病(DLBD)。结论认为DLBD可贡献于LPA表型,可能源于α-突触核蛋白相关的主导顶叶功能损害。

要点

  • LPA患者中DLBD是除AD外可贡献表型的病理基础。
  • LPA-DLBD的α-突触核蛋白负荷高于典型DLB-DLBD。

核心结论

  • AD是LPA最常见的潜在病理,但DLBD也可存在并可能贡献于LPA表型。

研究设计与样本

  • 诊所病理病例对照研究,共45例患者,含20例前瞻性招募的LPA患者,其中6例诊断为LPA-DLBD。

主要发现

  • LPA-DLBD患者均为男性,神经科、言语及神经心理特征与LPA-AD和LPA-FTLD相似。
  • LPA-DLBD中83%携带APOE ε4等位基因,AD、DLBD和FTLD相关基因筛查除APOE ε4外均为阴性。
  • 与pDLB相比,LPA-DLBD低代谢更不对称、累及额叶,非优势半球枕叶相对保留。
  • 与DLB-DLBD相比,LPA-DLBD大体脑检查萎缩轻微,皮质路易体计数更高,中额叶和下顶叶皮层α-突触核蛋白负荷更高。

临床怎么用

  • LPA表型患者需考虑DLBD作为潜在病理,尤其男性及APOE ε4携带者。
  • FDG-PET示顶叶优势低代谢时,应警惕DLBD贡献于LPA表型的可能。

局限性

  • LPA-DLBD样本量小(6例),结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to describe clinical features, [18 F]-fluorodeoxyglucose (FDG)-positron emission tomography (PET) metabolism and digital pathology in patients with logopenic progressive aphasia (LPA) and pathologic diagnosis of diffuse Lewy body disease (DLBD) and compare to patients with LPA with other pathologies, as well as patients with classical features of probable dementia with Lewy bodies (pDLB). METHODS: This is a clinicopathologic case-control study of 45 patients, including 20 prospectively recruited patients with LPA among whom 6 were diagnosed with LPA-DLBD. We analyzed clinical features and compared FDG-PET metabolism in LPA-DLBD to an independent group of patients with clinical pDLB and regional α-synuclein burden on digital pathology to a second independent group of autopsied patients with DLBD pathology and antemortem pDLB (DLB-DLBD). RESULTS: All patients with LPA-DLBD were men. Neurological, speech, and neuropsychological characteristics were similar across LPA-DLBD, LPA-Alzheimer's disease (LPA-AD), and LPA-frontotemporal lobar degeneration (LPA-FTLD). Genetic screening of AD, DLBD, and FTLD linked genes were negative with the exception of APOE ε4 allele present in 83% of LPA-DLBD patients. Seventy-five percent of the patients with LPA-DLBD showed a parietal-dominant pattern of hy pometabolism; LPA-FTLD - temporal-dominant pattern, whereas LPA-AD showed heterogeneous patterns of hypometabolism. LPA-DLBD had more asymmetrical hypometabolism affecting frontal lobes, with relatively spared occipital lobe in the nondominantly affected hemisphere, compared to pDLB. LPA-DLBD had minimal atrophy on gross brain examination, higher cortical Lewy body counts, and higher α-synuclein burden in the middle frontal and inferior parietal cortices compared to DLB-DLBD. INTERPRETATION: Whereas AD is the most frequent underlying pathology of LPA, DLBD can also be present and may contribute to the LPA phenotype possibly due to α-synuclein-associated functional impairment of the dominant parietal lobe. ANN NEUROL 2021;89:520-533.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Buciuc M, Whitwell JL, Kasanuki K, et al. Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype. Ann Neurol. 2020. PMID: 33274526. doi:10.1002/ana.25979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。